The Extended Multidomain Solution Structures of the Complement Protein Crry and its Chimeric Conjugate Crry-Ig by Scattering, Analytical Ultracentrifugation and Constrained Modelling: Implications for Function and Therapy

This publication has 53 references indexed in Scilit:

• Solution structures of complement components by X-ray and neutron scattering and analytical ultracentrifugation
  Biochemical Society Transactions, 2002
• Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
  The Journal of Experimental Medicine, 2002
• Complement Inhibitor, Complement Receptor 1-Related Gene/Protein y-Ig Attenuates Intestinal Damage After the Onset of Mesenteric Ischemia/Reperfusion Injury in Mice
  The Journal of Immunology, 2001
• Phenotypes of complement knockouts
  Immunopharmacology, 2000
• A Critical Role for Murine Complement Regulator Crry in Fetomaternal Tolerance
  Science, 2000
• Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury
  Immunopharmacology, 1999
• Transgenic Mice Overexpressing the Complement Inhibitor Crry as a Soluble Protein Are Protected from Antibody-induced Glomerular Injury
  The Journal of Experimental Medicine, 1998
• Production of the Rat Complement Regulator, Crry, as an Active Soluble Protein inPichia pastoris
  Archives of Biochemistry and Biophysics, 1997
• Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
  The Journal of Experimental Medicine, 1995
• Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.
  The Journal of Experimental Medicine, 1992